Characterization of urinary isoflavone metabolites excreted after the consumption of soy flour or soybean paste using lc-(esi)ms/ms

Journal of Food Biochemistry

Volumn 35, Issue 5, 2011, Pages 1474-1485

  Koh, Eunmi ^a   Mitchell, Alyson E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONES; BIOLOGICAL ACTIONS; CHEMICAL COMPOSITIONS; DAIDZEIN; DIETARY EXPOSURE; GENISTEIN; GLUCURONIDES; HUMAN HEALTH; ISOFLAVONES; SOY FLOUR; SOY FOODS; SOY ISOFLAVONES;

BIOCHEMISTRY; ENZYMATIC HYDROLYSIS; METABOLISM; METABOLITES; SUGARS;

BIOMOLECULES;

GLYCINE MAX;

EID: 80053482204     PISSN: 01458884     EISSN: 17454514     Source Type: Journal    
DOI: 10.1111/j.1745-4514.2010.00469.x     Document Type: Article

References (47)

1. ADLERCREUTZ, H., WILDT, J., KINZEL, J., ATTALLA, H., WAHALA, K., MAKELA, T., HASE, T. and FOTSIS, T. 1995. Lignan and isoflavonoid conjugates in human urine. J. Steroid Biochem. Mol. Biol. 52, 97-103.
2. AKAZA, H., MIYANAGA, N., TAKASHIMA, N., NAITO, S., HIRAO, Y., TSUKAMOTO, T., FUJIOKA, T., MORI, M., KIM, W.J., SONG, J.M. ETAL. 2004. Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn. J. Clin. Oncol. 34, 86-89.
3. ATKINSON, C., SKOR, H.E., FITZGIBBONS, E.D., SCHOLES, D., CHEN, C., WAHALA, K., SCHWARTZ, S.M. and LAMPE, J.W. 2002. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol. Biomarkers Prev. 11, 253-260.
4. ATKINSON, C., FRANKENFELD, C.L. and LAMPE, J.W. 2005. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp. Biol. Med. 230, 155-170.
5. BIRT, D.F., HENDRICH, S. and WANG, W. 2001. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol. Ther. 90, 157-177.
6. CASSIDY, A., BROWN, J.E., HAWDON, A., FAUGHNAN, M.S., KING, L.J., MILLWARD, J., ZIMMER-NECHEMIAS, L., WOLFE, B. and SETCHELL, K.D.R. 2006. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136, 45-51.
7. 3]isoflavone internal standards. Anal. Biochem. 309, 158-172.
8. COLDHAM, N.G., HOWELLS, L.C., SANTI, A., MONTESISSA, C., LANGLAIS, C., KING, L.J., MACPHERSON, D.D. and SAUER, M.J. 1999. Biotransformation of genistein in the rat: Elucidation of metabolite structure by product ion mass fragmentology. J. Steroid Biochem. Mol. Biol. 70, 169-184.
9. COLDHAM, N.G., DARBY, C., HOWS, M., KING, L.J., ZHANG, A.Q. and SAUER, M.J. 2002. Comparative metabolism of genistein by human and rat gut microflora: Detection and identification of the end-products of metabolism. Xenobiotica 32, 45-62.
10. COWARD, L., BARNES, N.C., SETCHELL, K.D.R. and BARNES, S. 1993. Genistein, daidzein, and their β-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem. 41, 1961-1967.
11. DAI, Q., FRANKE, A.A., JIN, F., SHU, X.O., HEBERT, J.R., CUSTER, L.J., CHENG, J.R., GAN, Y.T. and ZHENG, W. 2002. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol. Biomarkers Prev. 11, 815-821.
12. DE KLEIJN, M.J.J., VAN DER SCHOUW, Y.T., WILSON, P.W.F., GROBBEE, D.E. and JACQUES, P.F. 2002. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US women: The Framingham study. J. Nutr. 132, 276-282.
13. DO, M.H., LEE, S.S., JUNG, P.J. and LEE, M.H. 2007. Intake of fruits, vegetables, and soy foods in relation to breast cancer risk in Korean women: A case-control study. Nutr. Cancer 57, 20-27.
14. DOERGE, D.R., CHANG, H.C., CHURCHWELL, M.I. and HOLDER, C.L. 2000. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. 28, 298-307.
15. FANG, N., YU, S. and BADGER, T.M. 2002. Characterization of isoflavones and their conjugates in female rat urine using LC/MS/MS. J. Agric. Food Chem. 50, 2700-2707.
16. FAUGHAN, M.S., HAWDON, A., AH-SINGH, E., BROWN, J., MILLWARD, D.J. and CASSIDY, A. 2004. Urinary isoflavone kinetics: The effect of age, gender, food matrix and chemical composition. Br. J. Nutr. 91, 567-574.
17. HUR, H.G., LAY, J.O., BEGER, R.D., FREEMAN, J.P. and RAFII, F. 2000. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch. Microbiol. 174, 422-428.
18. HUTCHINS, A.M., SLAVIN, J.L. and LAMPE, J.W. 1995. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Assoc. 95, 545-551.
19. ISMAIL, B. and HAYES, K. 2005. β-glycosidase activity toward different glycosidic forms of isoflavones. J. Agric. Food Chem. 53, 4918-4924.
20. IZUMI, T., PISKULA, M.K., OSAWA, S., OBATA, A., TOBE, K., SAITO, M., KATAOKA, S., KUBOTA, Y. and KIKUCHI, M. 2000. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 130, 1695-1699.
21. KING, R.A. and BURSILL, D.B. 1998. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. 67, 867-872.
22. KINJO, J., TSUCHIHASHI, R., MORITO, K., HIROSE, T., AOMORI, T., NAGAO, T., OKABE, H., NOHARA, T. and MASAMUNE, Y. 2004. Interactions of phytoestrogens with estrogen receptors α and β (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol. Pharm. Bull. 27, 185-188.
23. KOH, E. and MITCHELL, A.E. 2007. Urinary isoflavone excretion in Korean adults: Comparisons of fermented soybean paste and unfermented soy flour. J. Sci. Food Agric. 87, 2112-2120.
24. LAMPE, J.W. 2003. Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J. Nutr. 133, 956S-964S.
25. MARKIEWICZ, L., GAREY, J., ADLERCREUTZ, H. and GURPIDE, E. 1993. In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45, 399-405.
26. RAFII, F., DAVIS, C., PARK, M., HEINZE, T.M. and BEGER, R.D. 2003. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch. Microbiol. 180, 11-16.
27. RICHELLE, M., PRIDMORE-MERTEN, S., BODENSTAB, S., ENSLEN, M. and OFFORD, E.A. 2002. Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr. 132, 2587-2592.
28. RITCHIE, M.R., MORTON, M.S., THOMPSON, A.M., DEIGHTON, N., BLAKE, A., CUMMINGS, J.H. and STEEL, C.M. 2004. Investigation of the reliability of 24h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes. Eur. J. Clin. Nutr. 58, 1286-1289.
29. RUFER, C.E. and KULLING, S.E. 2006. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem. 54, 2926-2931.
30. SETCHELL, K.D.R. and CASSIDY, A. 1999. Dietary isoflavones: Biological effects and relevance to human health. J. Nutr. 129, 758S-767S.
31. SETCHELL, K.D.R., BROWN, N.M., ZIMMER-NECHEMIAS, L., BRACHEAR, W.T., WOLFE, B.E., KIRSCHNER, A.S. and HEUBI, J.E. 2002. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 76, 447-453.
32. SETCHELL, K.D.R., BROWN, N.M., DESAI, P.B., ZIMMER-NECHIMIAS, L., WOLFE, B., JAKATE, A.S., CREUTZINGER, V. and HEUBI, J.E. 2003. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr. 133, 1027-1035.
33. SHELNUTT, S.R., CIMINO, C.O., WIGGINS, P.A. and BADGER, T.M. 2000. Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein. Cancer Epidemiol. Biomarkers Prev. 9, 413-419.
34. SHELNUTT, S.R., CIMINO, C.O., WIGGINS, P.A., RONIS, M.J.J. and BADGER, T.M. 2002. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am. J. Clin. Nutr. 76, 588-594.
35. SHIMOI, K., SAKA, N., NOZAWA, R., SATO, M., AMANO, I., NAKAYAMA, T. and KINAE, N. 2001. Deglucuronidation of flavonoids, luteolin monoglucuronide, during inflammation. Drug Metabol. Dispos. 29, 1521-1524.
36. SLAVIN, J.L., KARR, S.C., HUTCHINS, A.M. and LAMPE, J.W. 1998. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am. J. Clin. Nutr. 68, 1492-1495.
37. SONG, K.B., ATKINSON, C., FRANKENFELD, C.L., JOKELA, T., WAHALA, K., THOMAS, W.K. and LAMPE, J.W. 2006. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J. Nutr. 136, 1347-1351.
38. STOB, M. 1983. Naturally occurring food toxicants: Oestrogen. In Handbook of Naturally Occuring Food Toxicants (L. Recheigg, ed.) pp. 81-100, CRC, Boca Raton, FL.
39. SURH, J., KIM, M.J., KOH, E., KIM, Y.K. and KWON, H. 2006. Estimated intakes of isoflavones and coumestrol in Korean population. Int. J. Food Sci. Nutr. 57, 325-344.
40. TOTTA, P., ACCONCIA, F., VIRGILI, F., CASSIDY, A., WEINBERG, P.D., RIMBACH, G. and MARINO, M. 2005. Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-β in cultured human cancer cells. J. Nutr. 135, 2687-2693.
41. WANG, H. and MURPHY, P.A. 1996. Mass balance study of isoflavones during soybean processing. J. Agric. Food Chem. 44, 2377-2383.
42. WATANABE, S., YAMAGUCHI, M., SOBUE, T., TAKAHASHI, T., MIURA, T., ARAI, Y., MAZUR, W., WAHALA, K. and ADLERCREUTZ, H. 1998. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60g baked soybean powder (kinako). J. Nutr. 128, 1710-1715.
43. WONG, C.K. and KEUNG, W.M. 1997. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem. Biophys. Res. Commun. 233, 579-583.
44. XU, X., HARRIS, K.S., WANG, H.J., MURPHY, P.A. and HENDRICH, S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125, 2307-2315.
45. ZHANG, Y., SONG, T.T., CUNNICK, J.E., MURPHY, P.A. and HENDRICH, S. 1999. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J. Nutr. 129, 399-405.
46. ZHANG, Y., HENDRICH, S. and MURPHY, P.A. 2003. Glucuronides are the main isoflavone metabolites in women. J. Nutr. 133, 399-404.
47. ZUBIK, L. and MEYDANI, M. 2003. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 77, 1459-1465.